NimbuDerm(TM) Receives Wound Healing Society's Prestigious Blue Ribbon Award

GAINESVILLE, Fla.--(Business Wire)--
Quick-Med Technologies, Inc. is pleased to announce that a team of
scientists from Quick-Med received the Blue Ribbon Award at the
Symposium on Advanced Wound Care and Wound Healing Society's 21st
Annual Meeting for the outstanding abstract entitled: "Persistent Skin
Sanitizer (NimbuDerm(TM)) with Sustained Microbicidal Properties." The
abstract was sponsored by Quick-Med Technologies and the University of
Florida at Gainesville.

The Wound Healing Society offers the Blue Ribbon Industrial
Research & Development Award to recognize the best product-oriented
research performed by research and development scientists within the
corporate world. This year, a total of 11 blue ribbons were awarded
including 2 to teams from Quick-Med Technologies. Other participants
at the SAWC/WHS event were prominent companies such as Johnson &
Johnson Wound Management, 3M Healthcare, Kinetic Concepts, Inc., and
Healthpoint, Ltd., as well as leading educational institutions such as
the Harvard Medical School, Stanford University, and the University of
Pennsylvania School of Medicine.

"We are honored to receive this important recognition from such a
prestigious organization as the Wound Healing Society," said J. Ladd
Greeno, CEO of Quick-Med Technologies. "NimbuDerm technology
represents an important breakthrough that has the potential to
dramatically improve hand hygiene by combining the power of an instant
sanitizer with long-lasting personal protection."

This project team is lead by David Moore(1) and includes William
Toreki(1), Roy Carr(1), Gregory Schultz(1,2), Christopher Batich(1,2),
Albina Mikhaylova(1), Jillian Vella(1), and Gerald Olderman(1).
((1)Quick-Med Technologies, Inc.; (2)University of Florida)

Human use tests show that NimbuDerm is both instant and provides a
high level of continuing antimicrobial protection for 6 hours after
application without wearing off or losing its effectiveness. Poor hand
hygiene is considered to be a major contributor to the spread of
infectious diseases and the increase of potentially deadly
methicillin-resistant Staphylococcus aureus, or MRSA infections.

NimbuDerm, an extension of Quick-Med's NIMBUS(R) technology, opens
up new application vistas as a result of its liquid form, unique
properties, and formulation flexibility.

The poster in its entirety can be accessed by clicking here.

About the Wound Healing Society

The Wound Healing Society is a non-profit organization composed of
clinical and basic scientists. The Society provides a forum for
interaction among scientists, physicians, licensed practitioners,
industrial representatives and government agencies. Founded in 1990,
the Society is recognized among professionals and government agencies
as the leading scientific organization focused in this area of wound
healing. The Society publishes the leading journal in this area, Wound
Repair and Regeneration.

About Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc. is a life sciences company that is
developing innovative technologies for the healthcare and consumer
markets. For more information, see: www.quickmedtech.com.

(C) 2008 Quick-Med Technologies, Inc. All rights reserved.
NIMBUS(R) is a registered trademark and NimbuDerm(TM) is a trademark
of Quick-Med Technologies, Inc.

Forward-looking statements (statements which are not historical
facts) in this release are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. For this
purpose, any statements contained in this release that are not
statements of historical fact may be deemed to be forward-looking
statements. Without limiting the generality of the foregoing, words
such as "may", "will", "to," "expect," "plan," "believe,"
"anticipate," "intend," "could," "would," "estimate," and/or
"continue" or the negative or other variations thereof or comparable
terminology is intended to identify forward-looking statements involve
risks and uncertainties, including those risks that are discussed in
the Company's filings with the Securities and Exchange Commission
("SEC"), which may be accessed at the SEC's Edgar System at
www.sec.gov.

Quick-Med Technologies, Inc.
Investor & Media Relations:
Natasha A. Sorobey, 888-835-2211, ext. 107
info@quickmedtech.com

Copyright Business Wire 2008